Drug-of-Abuse Testing at the Point of Care

Clinics in Laboratory Medicine

Volumn 29, Issue 3, 2009, Pages 503-509

  Melanson, Stacy E F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Clinical laboratory; Drugs of abuse; Emergency department; Pain management; Point of care; Substance abuse

Indexed keywords

ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ANALYTICAL PARAMETERS; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; IMMUNOASSAY; LABORATORY TEST; MEDICAL DOCUMENTATION; PATIENT CARE; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SENSITIVITY AND SPECIFICITY; URINALYSIS;

GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; POINT-OF-CARE SYSTEMS; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 70349973651     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2009.06.010     Document Type: Review

References (24)

1. Watson I. Clinical drug testing at the point of care. 2nd edition (2004), AACC Press, Washington (DC)
2. Wu A.H., McKay C., Broussard L.A., et al. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem 49 3 (2003) 357-379
3. Heit H.A., and Gourlay D.L. Urine drug testing in pain medicine. J Pain Symptom Manage 27 3 (2004) 260-267
4. Trescot A.M., Boswell M.V., Atluri S.L., et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 9 1 (2006) 1-39
5. Lewandrowski K., Flood J., Finn C., et al. Implementation of point-of-care rapid urine testing for drugs of abuse in the emergency department of an academic medical center: impact on test utilization and ED length of stay. Am J Clin Pathol 129 5 (2008) 796-801
6. George S., and Braithwaite R.A. Use of on-site testing for drugs of abuse. Clin Chem 48 10 (2002) 1639-1646
7. Hicks J.M., Haeckel R., Price C.P., et al. Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium. Clin Chim Acta 303 1-2 (2001) 1-17
8. Watson I., Bertholf R., Hammett-Stabler C., et al. Drugs and ethanol (2006), National Academy of Clinical Biochemistry, Washington (DC)
9. Leino A., Saarimies J., Gronholm M., et al. Comparison of eight commercial on-site screening devices for drugs-of-abuse testing. Scand J Clin Lab Invest 61 4 (2001) 325-331
10. Pil K., and Verstraete A. Current developments in drug testing in oral fluid. Ther Drug Monit 30 2 (2008) 196-202
11. Bendtsen P., Hultberg J., Carlsson M., et al. Monitoring ethanol exposure in a clinical setting by analysis of blood, breath, saliva, and urine. Alcohol Clin Exp Res 23 9 (1999) 1446-1451
12. Haller C.A., Stone J., Burke V., et al. Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory. J Anal Toxicol 30 2 (2006) 106-111
13. Leino A., and Loo B.M. Comparison of three commercial tests for buprenorphine screening in urine. Ann Clin Biochem 44 Pt 6 (2007) 563-565
14. Phillips J.E., Bogema S., Fu P., et al. Signify ER Drug Screen Test evaluation: comparison to Triage Drug of Abuse Panel plus tricyclic antidepressants. Clin Chim Acta 328 1-2 (2003) 31-38
15. Schwartz J.G., Hurd I.L., and Carnahan J.J. Determination of tricyclic antidepressants for ED analysis. Am J Emerg Med 12 5 (1994) 513-516
16. Yang J.M., and Lewandrowski K.B. Urine drugs of abuse testing at the point-of-care: clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT). Clin Chim Acta 307 1-2 (2001) 27-32
17. de la Torre R., Domingo-Salvany A., Badia R., et al. Clinical evaluation of the Triage analytic device for drugs-of-abuse testing. Clin Chem 42 9 (1996) 1433-1438
18. Mastrovitch T.A., Bithoney W.G., DeBari V.A., et al. Point-of-care testing for drugs of abuse in an urban emergency department. Ann Clin Lab Sci 32 4 (2002) 383-386
19. Poklis A., Poklis J.L., Tarnai L.D., et al. Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine. J Anal Toxicol 28 6 (2004) 485-488
20. Taylor E.H., and Pizzo P. Evaluation of the DrugCheck 9 on-site immunoassay test cup according to a standard method validation protocol. J Anal Toxicol 28 3 (2004) 190-197
21. Moody D.E., Fang W.B., Andrenyak D.M., et al. A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry. J Anal Toxicol 30 1 (2006) 50-56
22. Tomaszewski C., Runge J., Gibbs M., et al. Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity. J Emerg Med 28 4 (2005) 389-394
23. Wu A.H., Wong S.S., Johnson K.G., et al. Evaluation of the triage system for emergency drugs-of-abuse testing in urine. J Anal Toxicol 17 4 (1993) 241-245
24. Taylor E.H., Oertli E.H., Wolfgang J.W., et al. Accuracy of five on-site immunoassay drugs-of-abuse testing devices. J Anal Toxicol 23 2 (1999) 119-124